SYK 88.30 Stryker Corp $SYK Hit a 52 week high of 88.64

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
SYK 88.30 Stryker Corp $SYK Hit a 52 week high of 88.64 Closing the day 09:45 at 88.30 -0.54 -0.61% With a day low of 88.30 and a total volume of 43,843.

SYK Recent Posts: http://investorshangout.com/Stryker-Corp-SYK-52773/

SYK Stryker Corp Recent Headline News

Stryker Hip Recall Products (Rejuvenate and ABG II) Settle for $1 Billion; Largest Individual Base Payment Awards to Date in Mass Tort Hip Implant Settlement, Says Lawsuitsettlementnews.com
PR Newswire - Fri Nov 14, 4:00AM CST
MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today a prime focus on assisting plaintiffs who have suffered with complications from a Stryker hip implant due to the $1 billion settlement that was announced last week by Stryker Corporation. People who have received the Stryker Rejuvenate and ABG II hip replacement devices and subsequently had them removed are qualified to participate in the settlement, which was reached in State Superior Court in Hackensack, New Jersey and in Federal Court in Minnesota. However, those who sued prior to device failure without replacement surgery before November 3rd are not eligible to partake in the settlement, but according to lawyers in NorthJersey.com, they "could be covered in a future round of negotiations" with Stryker Corp.
SYK: 87.84 (-1.00)

BRIC Pressure Relief Devices Market Outlook to 2020: Key Vendors are Hill-Rom Holdings, Inc., France BED and ArjoHuntleigh.
M2 - Thu Nov 13, 3:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/mvhzdg/bric_pressure) has announced the addition of the "BRIC Pressure Relief Devices Market Outlook to 2020" report to their offering. "BRIC Pressure Relief Devices Market Outlook to 2020", provides key market data on the BRIC Pressure Relief Devices Therapy market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Pressure Relief Devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Pressure Relief Devices market. - Global corporate-level profiles of key companies operating within the BRIC Pressure Relief Devices. Market Segments - Specialty Beds Rental Business - Specialty Beds Sales Business - Mattresses (Static and Dynamic Mattresses) - Mattress Overlays (Static and Dynamic Mattress Overlays) Companies Mentioned - ArjoHuntleigh - Hill-Rom Holdings, Inc. - France Bed Holdings Co.,Ltd. - Young Won Medical Co., Ltd - Stryker Corporation - Foshan City Mianzhibao Furniture Co., Ltd. - Apex Medical Corporation - Paramount Bed Co., Ltd. - Zhangjiagang Bestran Technology Co.,Ltd - Seahonence Inc. - Invacare Corporation - Linet spol s.r.o. - Drive Medical For more information visit http://www.researchandmarkets.com/research/mv...c_pressure
IVC: 16.51 (+0.52), HRC: 44.52 (-0.51), SYK: 87.84 (-1.00)

Stryker Spine To Launch Innovative Anchor-based ALIF Technology At The North American Spine Society Annual Meeting
PR Newswire - Wed Nov 12, 9:00AM CST
Stryker Corporation's Spine Division will be launching its innovative Anchor-based ALIF technology, Aero(TM)-AL, at booth #1405 during the North American Spine Society's Annual Meeting in San Francisco, CA from November 12 - 14.
SYK: 87.84 (-1.00)

North America Pressure Relief Devices Market Outlook to 2020: Key Players are Hill-Rom Holdings, Inc., Invacare Corporation and ArjoHuntleigh.
M2 - Wed Nov 12, 5:50AM CST
Research and Markets (http://www.researchandmarkets.com/research/9r8r6t/north_america) has announced the addition of the "North America Pressure Relief Devices Market Outlook to 2020" report to their offering. "North America Pressure Relief Devices Market Outlook to 2020", provides key market data on the North America Pressure Relief Devices Therapy market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Pressure Relief Devices market. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Market Segments - Specialty Beds Rental Business - Specialty Beds Sales Business - Mattresses (Static and Dynamic Mattresses) - Mattress Overlays (Static and Dynamic Mattress Overlays) Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Pressure Relief Devices Market, North America 4 Pressure Relief Devices Market, Canada 5 Pressure Relief Devices Market, Mexico 6 Pressure Relief Devices Market, United States 7 Overview of Key Companies in North America Pressure Relief Devices Market 8 Pressure Relief Devices Market Pipeline Products 9 Recent Developments 10 Appendix Companies Mentioned - Hill-Rom Holdings, Inc. - ArjoHuntleigh - Invacare Corporation - Stryker Corporation - Linet spol s.r.o. - FXI, Inc. For more information visit http://www.researchandmarkets.com/research/9r...th_america
IVC: 16.51 (+0.52), HRC: 44.52 (-0.51), SYK: 87.84 (-1.00)

Stryker Spine To Launch Unique Minimally Invasive Procedural Solution At The North American Spine Society Annual Meeting
PR Newswire - Tue Nov 11, 2:02PM CST
Stryker Corporation's Spine Division will be launching its innovative LITe® (Less Invasive Technology) TLIF Procedural Solution at booth #1405 during the North American Spine Society's Annual Meeting in San Francisco, CA from November 12 - 14.
SYK: 87.84 (-1.00)

Proposed Settlement in U.S. Stryker Hip Implant Litigation
CNW Group - Tue Nov 11, 9:20AM CST
The law firms Koskie Minsky LLP, Stevensons LLP and Klein Lyons announce that Stryker Corporation has agreed to pay more than $1 billion to resolve lawsuits over thousands of metal-on-metal hip implants in the United States.
SYK: 87.84 (-1.00)

Asia-Pacific Pressure Relief Devices Market Outlook to 2020 in New Research Report Available at ReportsnReports.com
PRWeb - Mon Nov 10, 10:30PM CST
"Asia-Pacific Pressure Relief Devices Market Outlook to 2020", provides key market data on the Asia-Pacific Pressure Relief Devices Therapy market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Specialty Beds Rental Business Specialty Beds Sales Business Mattresses (Static and Dynamic Mattresses) Mattress Overlays (Static and Dynamic Mattress Overlays) The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Pressure Relief Devices market wherever available. Complete Report Available @ http://www.reportsnreports.com/reports/314876...-2020.html . The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Overview of Key Companies in Asia-Pacific Pressure Relief Devices Market: France Bed Holdings Co.,Ltd. Hill-Rom Holdings, Inc. ArjoHuntleigh Apex Medical Corporation Seahonence Inc. Stryker Corporation Paramount Bed Co., Ltd. Young Won Medical Co., Ltd Foshan City Mianzhibao Furniture Co., Ltd. Order a Purchase copy @ http://www.reportsnreports.com/Purchase.aspx?name=314876 . Scope Market size data for Pressure Relief Devices market segments - Specialty Beds Rental Business, Specialty Beds Sales Business, Mattresses and Mattress Overlays. Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. 2013 company shares and distribution shares data for Pressure Relief Devices market. Global corporate-level profiles of key companies operating within the Asia-Pacific Pressure Relief Devices. Key players covered include Hill-Rom Holdings, Inc., France BED and ArjoHuntleigh. Reasons to buy Develop business strategies by identifying the key market categories and segments poised for strong growth in the future. Develop market-entry and market expansion strategies. Design competition strategies by identifying who-stands-where in the market. Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
HRC: 44.52 (-0.51), SYK: 87.84 (-1.00)

Medical Device Companies Were Election Day Winners
Todd Campbell, The Motley Fool - Motley Fool - Sat Nov 08, 11:00AM CST
Source: Library of Congress The shift in power in Washington may have big implications for medical device companies if legislation is rekindled to ditch the 2.3% medical device tax. That tax, enacted as part of Obamacare to help fund the cost of...
BIIB: 305.28 (-12.70), MDT: 68.92 (-0.46), AMGN: 156.89 (-3.96), SYK: 87.84 (-1.00)

Global Bio-implants Market (Types, and geography) - Forecast to 2020
M2 - Fri Nov 07, 6:14AM CST
Research and Markets (http://www.researchandmarkets.com/research/57vlzn/global) has announced the addition of the "Global Bio-implants Market (Types, and geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020 " report to their offering. Bio-implants have emerged as a promising solution for the variety of conditions such as cardiovascular, dental, orthopedic, ophthalmology, neurological disorders and others. Global bio implants market is forecast to reach $115.8 billion by 2020. High prevalence of disease conditions such as cardiovascular, orthopedic and spinal disorders that can be treated via bio implants are the key drivers of the bio implants market. According to American College Of Surgeons, 29% of the trauma injuries were caused by road accidents; the instances of road accidents and death due to the same are rising to about 2.2% globally. Such patients undergoing traumatic injuries can be effectively treated with bio implants. Such afore-mentioned factor and multifarious analogous factors across cardiovascular, spinal and ophthalmic disorders drive the growth of the bio implants market. The global bio-implants market is segmented based on product types and geography. Within the product types, the bio implants market is segmented into cardiovascular, dental and prosthetic implants, orthopedic/joint reconstruction and replacement bio implants, spinal bio implants, ophthalmology bio implants and others. Geographically, the market is segmented into four regions, namely North America, Europe, Asia-Pacific and LAMEA. Key Topics Covered: CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 GLOBAL BIOIMPLANTS MARKET OVERVIEW CHAPTER 4 GLOBAL BIO IMPLANTS MARKET BY TYPES CHAPTER 5 GLOBAL BIO IMPLANTS MARKET BY GEOGRAPHY CHAPTER 6 EUROPEAN BIO IMPLANTS MARKET ANALYSIS CHAPTER 7 COMPANY PROFILE Companies Mentioned: - B.Braun - BIOMET (Zimmer) - Biotroni - DENTSPLY International - DePuy Synthes - Ethicon Inc. - Invibio Biomaterial Solutions - kasios - KLS Martin - Mediplus - Medtronic, Inc. - SBM (Science for Biomaterials) - Smith & Nephews - Stryker Corporation - Wright Medical Group For more information visit http://www.researchandmarkets.com/research/57vlzn/global
MDT: 68.92 (-0.46), WMGIZ: 4.47 (-0.01), XRAY: 51.95 (+0.09), SYK: 87.84 (-1.00)

2 Health Care Stocks to Watch on GOP Congressional Takeover - Stocks in the News
Zacks Research Staff - Zacks Investment Research - Thu Nov 06, 4:02PM CST
These health care stocks could benefit if Republicans push for changes in the medical sector.
BSX: 13.38 (-0.03), SYK: 87.84 (-1.00), HUM: 135.49 (-2.92)

Stryker Receives Prestigious 2014 Prix Galien Award For Best Medical Technology
PR Newswire - Thu Nov 06, 2:09PM CST
Stryker Corporation's Trevo® ProVue Retriever has received the Prix Galien USA 2014 Award for Best Medical Technology. The Trevo ProVue Retriever is designed to restore blood ïeow in the neurovasculature by removing blood clot in patients experiencing ischemic stroke. The Trevo ProVue Retriever is the first and only Stentriever® Device fully visible under fluoroscopic imaging, and sets a new standard in precision placement, visualization of the device/clot interaction and clot retrieval. This enhanced level of visibility provides physicians with real-time information not previously available.
SYK: 87.84 (-1.00)

Technical Coverage on Health Care Equipment Stocks - Boston Scientific, Zeltiq Aesthetics, Globus Medical, Volcano, and Stryker
PR Newswire - Thu Nov 06, 7:45AM CST
Investor-Edge has initiated coverage on the following equities: Boston Scientific Corporation (NYSE: BSX), Zeltiq Aesthetics Inc. (NASDAQ: ZLTQ), Globus Medical Inc. (NYSE: GMED), Volcano Corporation (NASDAQ: VOLC), and Stryker Corporation (NYSE: SYK). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Wednesday, November 5, 2014, the NASDAQ Composite ended at 4,620.72, down 0.06%, the Dow Jones Industrial Average advanced 0.58%, to finish the day at 17,484.53, and the S&P 500 closed at 2,023.57, up 0.57%. The gains were broad based as nine out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 778.22, down 0.19%, while the index has advanced 10.98% in the previous three months. Register for your complimentary reports on these five stocks at:
BSX: 13.38 (-0.03), ZLTQ: 27.44 (+0.67), GMED: 22.69 (-0.23), VOLC: 10.86 (+0.07), SYK: 87.84 (-1.00)

Italy Laparoscopes Market Outlook to 2020: Key players covered include Olympus, KARL STORZ GmbH & Co, B. Braun Melsungen and Intuitive Surgical
M2 - Thu Nov 06, 5:56AM CST
Research and Markets (http://www.researchandmarkets.com/research/zplm2z/italy) has announced the addition of the "Italy Laparoscopes Market Outlook to 2020" report to their offering. Our new report, "Italy Laparoscopes Market Outlook to 2020", provides key market data on the Italy Laparoscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Video Laparoscopes (Rigid Tip Video Laparoscopes and Flexible Tip Video Laparoscopes), Robotic Surgical Systems and Rigid Tip Non-Video Laparoscopes. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Laparoscopes market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Key Topics Covered: 1 List of Tables and Figures 2 Introduction 3 Laparoscopes Market, Italy 4 Overview of Key Companies in Italy, Laparoscopes Market 5 Appendix Companies Mentioned: - Olympus Corporation - Intuitive Surgical, Inc. - KARL STORZ GmbH & Co. KG - Stryker Corporation - B. Braun Melsungen AG For more information visit http://www.researchandmarkets.com/research/zplm2z/italy
ISRG: 514.00 (-2.10), SYK: 87.84 (-1.00)

India Hysteroscopes Market Outlook to 2020: Key players covered include Olympus, Hoya, Fujifilm and KARL STORZ GmbH & Co
M2 - Thu Nov 06, 5:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/m75gb2/india) has announced the addition of the "India Hysteroscopes Market Outlook to 2020" report to their offering. Our new report, "India Hysteroscopes Market Outlook to 2020", provides key market data on the India Hysteroscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Flexible Video Hysteroscopes and Non-Video Hysteroscopes (Rigid Non-Video Hysteroscopes and Flexible Non-Video (Fibre) Hysteroscopes). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Hysteroscopes market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Key Topics Covered: 1 List of Tables and Tables 2 Introduction 3 Hysteroscopes Market, India 4 Overview of Key Companies in India, Hysteroscopes Market 5 Appendix Companies Mentioned: - KARL STORZ GmbH & Co. KG - Olympus Corporation - Stryker Corporation - Richard Wolf GmbH For more information visit http://www.researchandmarkets.com/research/m75gb2/india
SYK: 87.84 (-1.00)

Germany Hysteroscopes Market Outlook to 2020: Key players covered include Olympus, Hoya, Fujifilm and KARL STORZ GmbH & Co
M2 - Thu Nov 06, 5:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/4br3r5/germany) has announced the addition of the "Germany Hysteroscopes Market Outlook to 2020" report to their offering. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Hysteroscopes market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Key Topics Covered: 1 List of Tables and Figures 2 Introduction 3 Hysteroscopes Market, Germany 4 Overview of Key Companies in Germany, Hysteroscopes Market 5 Appendix Companies Mentioned: - KARL STORZ GmbH & Co. KG - Olympus Corporation - Stryker Corporation - Richard Wolf GmbH For more information visit http://www.researchandmarkets.com/research/4br3r5/germany
SYK: 87.84 (-1.00)

Stryker to Present at Investor Conference
Thomson Reuters ONE - Wed Nov 05, 9:45AM CST
Kalamazoo, Michigan - November 5, 2014 - Stryker Corporation (NYSE:SYK) announced today that it will participate in the following investor conference:
SYK: 87.84 (-1.00)

Tracking Yacktman Asset Management Portfolio - Q3 2014 Update
John Vincent - at Seeking Alpha - Wed Nov 05, 5:56AM CST

BDX: 129.15 (-0.16), CHRW: 73.06 (-0.05), CLX: 99.76 (-2.15), SYY: 38.60 (-0.14), XOM: 94.75 (+0.09), WMT: 82.78 (-0.16), PDCO: 45.13 (-0.57), PEP: 97.52 (-1.02), JNJ: 108.08 (-0.99), FOX: 33.65 (+0.10), EBAY: 54.34 (-0.03), FOXA: 35.08 (+0.09), MSFT: 49.45 (-0.16), NWS: 14.98 (+0.17), BK: 39.62 (+0.03), CSCO: 26.32 (+0.64), SYK: 87.84 (-1.00), KO: 42.58 (-0.21), AVP: 10.03 (-0.23), BCR: 163.89 (-1.70), STT: 76.08 (-0.40), COP: 71.24 (+0.89), WFC: 53.27 (-0.12), WLP: 125.31 (-1.32), ORCL: 40.66 (-0.06), USB: 43.67 (-0.26), SIAL: 135.51 (-0.02), MRK: 58.90 (-0.64), PG: 87.94 (-0.66), VIAB: 72.91 (+1.71), CMCSA: 53.94 (-0.36)

Stryker Corporation and Subsidiary Howmedica Osteonics Jointly Announce Multi-Million-Dollar Settlement Involving Hip Implant Devices, Parker Waichman LLP Comments
PRWeb - Tue Nov 04, 4:01PM CST
Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs and medical devices notes that a settlement was just announced in the Stryker Corporation litigation involving the Rejuvenate and ABG II artificial hip implants. The multidistrict litigation (MDL) is: In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, MDL number 2441, before the U.S. Judicial Panel on Multidistrict Litigation.
SYK: 87.84 (-1.00)

Stryker (SYK) Stock Rose Today on $1.43 Billion Lawsuit Settlement
at The Street - Tue Nov 04, 3:27PM CST
Stryker (SYK) shares closed up after the company announced it was paying at least $1.43 billion to settle lawsuits against it,.
SYK: 87.84 (-1.00)

Landmark National Settlement Reached In Stryker Hip Replacement Lawsuits
PR Newswire - Tue Nov 04, 8:58AM CST
South Florida law firm Searcy Denney Scarola Barnhart & Shipley, P.A. (Searcy Denney) announced today that a national settlement has been reached on behalf of victims of the recalled Stryker Rejuvenate and ABG II hip replacement devices. It is estimated that Stryker and Howmedica Osteonics will pay well in excess of $1 billion to qualifying claimants under this settlement program.
SYK: 87.84 (-1.00)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 52

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 104

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 0

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading
Celebrating Case Managers: A Call to Action for 2025

Updated Category News Views 522

Recognizing the Contribution of Case Managers in 2025 Case managers have proven time and again to be essential contributors to the health and human services spectrum. In 2025, the two prominent organizations in the case management field—the American Case Management Association (ACMA) and the Commission for Case Manager Certification (CCMC)—have once again partnered to...

Continue Reading
Faruqi & Faruqi Investigates Ford Investor Claims

Updated Category News Views 92

Back in 2024, Faruqi & Faruqi took aim at Ford Motor Company (NYSE: F), investigating claims from investors who’d racked up losses over $100,000. They were diving deep into the financial mess at Ford—a colossal vehicle manufacturer that found itself knee-deep in allegations of breaching federal securities laws. The chatter was all about how quality assurance failures...

Continue Reading
Entourage Health Announces Going-Private Arrangement Plan

Updated Category News Views 236

Entourage Health Corp. Takes a Bold Step Toward Going-Private Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has officially entered into a significant arrangement agreement with 1001007762 Ontario Inc. and 2437653 Ontario Inc. This strategic move, a statutory plan under the Business Corporations Act (Ontario), sees the Purchaser agreeing to acquire all common shares...

Continue Reading
A&W Revenue Royalties Income Fund Q3 2024 Results Review

Updated Category News Views 183

A&W Revenue Royalties Income Fund Q3 2024 Financial Overview TRADING SYMBOL: TSX: AW.UN A&W Revenue Royalties Income Fund has reported encouraging results for the third quarter ending this year. The quarterly performance reflects steady royalty income growth and strategic developments that promise an exciting future. Royalty Income Performance In the third quarter of...

Continue Reading